Greenphire Named One of the Fastest-Growing U.S Companies
News Aug 21, 2013
The company has been ranked 192, and 21 in the software industry, on the seventh annual list which represents the most comprehensive look at America's independent entrepreneurs.
Sam Whitaker, CEO, Greenphire, comments: "We are delighted to have made this year's Inc. 500. The Greenphire team has worked relentlessly to achieve our success and we are proud to have joined the ranks with many of the nation's most high achieving and innovative companies."
Since Greenphire was founded in 2008, the business has gone from strength-to-strength, launching two groundbreaking clinical payment technologies and securing contracts with multiple top 30 pharmaceutical companies. In the past 12 months alone, Greenphire has more than doubled its team and has established strategic partnerships with a number of leading organizations.
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Comments | 0 ADD COMMENT
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017